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Ovarian cancer is the commonest cause of gynaecological cancer-
related death in the UK (Association of Cancer Physicians, 1994).
In the northwest of England, the annual incidence is 183 cases per
million and, between 1989 and 1991, 1085 cases were recorded in
the North West Cancer Registry (unpublished data).
The optimal management of ovarian carcinoma is defined in the
Scott Report (Scott, 1991) and 1993 consensus statements on
advanced epithelial ovarian cancer (Allen et al, 1993). These state
that an experienced gynaecological surgeon should attempt
optimum cytoreduction (debulking), including total abdominal
hysterectomy (TAH), bilateral salpingo-oophorectomy (BSO) and
infracolic omentectomy. Those with suspected early FIGO
(International Federation of Obstetricians & Gynaecologists) stage
disease (Shepherd, 1992) should have ascitic fluid or peritoneal
washings sent for cytological evaluation, together with random
peritoneal biopsies and diaphragmatic scrapings. Adhesions or
suspicious areas should be biopsied, and the liver and diaphragm
palpated to assess the extent of the disease. Some have also advo-
cated routine retroperitoneal lymphadenectomy. Those with more
advanced disease should undergo debulking of all macroscopic
disease. Patients should then have further appropriate staging
investigations and should receive chemotherapy from a non-
surgical oncologist who is trained in the field (Scott, 1991; Allen
et al, 1993). A multidisciplinary approach has been associated
with improved survival (Junor et al, 1994).
We have performed a retrospective audit of the initial surgical
management of patients with newly diagnosed epithelial ovarian
carcinoma referred for chemotherapy to the Department of
Medical Oncology at the Christie Cancer Centre in 1996. The aim
was to assess the compliance with surgical guidelines for the
management of epithelial ovarian carcinoma.
METHODS
Currently, all primary surgery for ovarian cancer in northwest
England is performed in district general hospitals. Women with
ovarian cancer can then be referred to a non-surgical oncologist at
the Christie Cancer Centre. All cases of ovarian cancer referred to
the Department of Medical Oncology during 1996 were included
in the audit, which was conducted using standard criteria (National
Centre for Clinical Audit, 1997).
A retrospective review of the Christie Hospital case notes, and
referring hospital correspondence, pathology reports and operation
notes, was performed to determine:
1. The presentation and pre-operative investigation of patients.
2. The surgery performed including a stage-specific (FIGO stage
I vs stages II–IV) analysis of surgery.
3. The information recorded in the operation notes.
RESULTS
In 1996, the Department of Medical Oncology received 87 refer-
rals for the post-operative management of ovarian cancer and the
case notes of 85 of these patients were available. Table 1 records
the characteristics of these patients.
Clinical presentation and pre-operative investigations
The mode of presentation of ovarian cancer was largely sub-acute.
Seventy-eight of the 85 (92%) patients presented with symptoms
that were first assessed in the out-patient clinic and then proceeded
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to elective surgical management. Seven cases (8%) presented
acutely, although four of these underwent detailed pre-operative
radiological assessment before elective surgery.
Abdomino-pelvic ultrasound scan (USS) or computerized
tomography (CT) scan were performed in 60 cases (15 women had
both; total 74%) and two women underwent magnetic resonance
imaging. Reference to the pre- or post-operative serum concentra-
tion of the tumour marker CA125 was made in only 14 cases
before referral to the Christie Cancer Centre.
Operating surgeons
Eighty-three patients were operated on by 31 gynaecologists and
four general surgeons from 14 district general hospitals (range
1–17 patients per hospital, median eight). Two patients were
excluded since one had refused surgery and another had recurrent
disease.
The number of consultants in each hospital who operated on a
patient with ovarian cancer was between one and seven (median
three). The range of patients operated on by each consultant was
1–11 (median one). Hence, in one hospital a single consultant
operated on 11 cases of ovarian cancer while in another seven
consultants operated on 17 patients (Figure 1).
Surgery
The recommendations for surgery in cases of suspected ovarian
cancer include a vertical abdominal incision, total abdominal
hysterectomy, bilateral salpingo-oophorectomy and omentectomy.
Clearly recorded details of the initial incision were found for 75
patients. Five patients had a transverse suprapubic (pfannenstiel)
incision, of whom four had undergone detailed pre-operative
radiological investigations. Otherwise the recommended vertical
abdominal incision was made in 93% of this group.
Further surgical details were available for the 83 patients, some
of whom had undergone previous gynaecological surgery. TAH
was performed in 48 of 76 patients who had not previously under-
gone hysterectomy (63%). BSO (or oophorectomy if an ovary had
been previously removed) was performed in 61 out of 81 patients
(75%). Infracolic omentectomy was performed in 41 of 83 cases
(49%). Overall, 76 patients had not undergone previous gynaeco-
logical surgery, and 32 (42%) of these underwent the full recom-
mended surgical procedure. Post-operative CT scanning showed
no evidence of residual disease in 13 of these 32 patients.
Stage-specific surgery
Twenty-four women had FIGO stage I ovarian cancer. The abdom-
inal incision was determined in 21 patients and a vertical incision
confirmed in 18 (86%). Ten of 22 patients (two had previous
surgery) underwent TAH, BSO and omentectomy (45%). Eleven
patients (46%) had peritoneal fluid or washings taken for cytolog-
ical examination. Only two patients (8%) had peritoneal biopsies
performed for detection of occult disease (both of suspicious
areas). There were no biopsies of adhesions, diaphragmatic scrap-
ings, or lymph node sampling.
Sixty-one patients had at least stage II ovarian cancer. Of these,
22 patients (36%) underwent TAH, BSO and omentectomy (or the
equivalent when previous gynaecological surgery had been
performed). At post-operative evaluation by CT scan, five patients
(8%) had no residual disease while 48 (79%) had bulk residual
disease (defined as more than 1.5 cm diameter).
Both requirement for chemotherapy and the prognosis were
determined by the FIGO stage and extent of residual disease. This
was determined by integrating information including histology,
radiology and the recorded surgical findings. Of 83 patients who
had surgery, the FIGO stage was recorded in 20 cases, and a state-
ment concerning residual disease made in 45 cases.
Table 1 Characteristics of patients referred with ovarian carcinoma (n = 85)
Characteristic No. of patients %
Age (median = 59 years)
<35 4 5
36–45 10 11
>45 71 84
FIGO stage
I2 4 2 8
II 5 6
III 38 45
IV 18 21
Bulk residual disease (>1.5 cm) (n = 84) (% of each
stage)
I 0/24 0
II 4 / 5 80
III 28 / 37 76
IV 15 / 18 83
Histologic type
Benign (on pathology review) 2 2
Not otherwise specified 13 15
Clear cell 5 6
Endometrioid 16 19
Mucinous 10 12
Serous 20 24
Other 11 13
Borderline malignancy/pseudomyxoma 8 9
Tumour differentiation (excluding (n = 77) (% of 77)
borderline cases)
Well 13 17
Moderately 19 25
Poor/undifferentiated 30 39
Not known 13 17
Benign 2 3
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Figure 1 Number of patients (grey bars) and surgeons (black bars) in each
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DISCUSSION
The initial management of patients with ovarian cancer is surgical.
This aims to establish the histological diagnosis, achieve optimal
cytoreduction and determine the stage of the disease. Guidelines
(Scott, 1991; Allen et al 1993) recommend that patients with
suspected ovarian cancer should undergo total abdominal
hysterectomy, bilateral salpingo-oophorectomy, infracolic omen-
tectomy and removal of all other visible tumour through a vertical
abdominal incision. For those patients who are believed to have
early stage disease, peritoneal fluid or washings should be sent
for cytological evaluation. Random biopsies of the peritoneum,
diaphragmatic scrapings, and palpation of viscera including the
liver should also be performed. Although sometimes recom-
mended, lymph node sampling in stage I disease is not a standard
procedure in the UK at present.
As a tertiary referral centre, the Christie Cancer Centre serves
the northwest region of England. The surgical workload comprises
patients with relapsed disease or surgery after chemotherapy.
Currently, all primary surgery in the region is performed in district
general hospitals. A minority of women with ovarian cancer are
then referred to a non-surgical oncologist. Between 1989 and
1991, the Christie Cancer Centre was referred 436 patients with
ovarian cancer, representing 40% of registered cases (unpublished
data).
Patient selection
This audit reports the surgical management of all the patients with
ovarian cancer referred to the Medical Oncology Department of
this regional Cancer Centre in 1996, a cohort corresponding to
approximately a quarter of the total number of regional cases.
Although the numbers are quite small, it is likely that this group is
representative of those who are receiving optimal treatment, as the
guidelines state that referral to a non-surgical oncologist should
always be considered following the diagnosis of ovarian cancer.
A number of important findings were made.
Clinical presentation and investigation
Most women presented as out-patients and were assessed radio-
logically before an elective laparotomy. Seven cases presented
acutely, but four were still investigated with detailed radiological
assessment before surgery was considered. The acute presentation
of ovarian carcinoma is therefore unusual and so the guideline
recommendations, which state that an experienced gynaecological
surgeon should perform the operation, do not appear unreasonable.
A further consequence of this mode of presentation is that a small
group of nominated consultants could specialize in ovarian cancer.
However, the data show that up to seven consultants in each
hospital operated on patients with ovarian cancer.
Surgery
Current recommendations suggest that patients should undergo
TAH, BSO and omentectomy, yet only 32 of 76 patients who had
not undergone previous gynaecological surgery underwent this
procedure. Surgery to this extent may not be possible because of
difficulty with the dissection of normal structures from tumour. In
stage I disease, however, where disease is confined to the ovaries,
technical difficulties are likely to be minimal but despite this we
found that only ten of 22 patients with stage I disease underwent
the full recommended procedures. Furthermore, in cases where a
hysterectomy is performed, an omentectomy should be possible,
but we recorded a TAH and BSO in more than 60% of cases and an
omentectomy in less than 50%. Conservative surgery might have
occurred because operators did not consider a diagnosis of ovarian
cancer, but 74% of patients underwent detailed pre-operative
radiological evaluation which might have been expected to suggest
pelvic malignancy. In addition, most of the patients had a vertical
abdominal incision, which is not routine in gynaecological
surgery, implying that a sinister pathology was, in fact, suspected.
Staging procedures
The recommended staging procedures for suspected stage I
ovarian carcinoma include microscopy of ascites or peritoneal
washings for malignant cells, with random peritoneal biopsies to
exclude occult disease. However, the data show that less than half
the cases underwent these procedures and only two patients had
peritoneal biopsies performed. Conservative surgery, where the
uterus and normal ovary are preserved, can be practised in younger
patients who wish to preserve their fertility. Nevertheless, only
four patients in this series were less than 35 years old (Table 1).
Recording of operative findings
Statements concerning the FIGO stage and the presence of residual
disease in referral letters or in the operation notes contribute to
advice given concerning prognosis and the decision concerning
further medical management. In this group of patients, only 44 of
83 referral letters or operation notes contained information about
residual disease, and only a quarter stated the FIGO stage.
CONCLUSIONS
This audit has shown that in northwest England many consultants
are operating on a few patients with ovarian cancer. This is not
because patients present as emergencies since most are seen as
out-patients and evaluated with detailed radiological assessments
before operation. In addition, many patients are not undergoing the
recommended surgery or staging procedures, although in part this
may be due to patients having genuinely inoperable disease. The
Royal College of Obstetricians and Gynaecologists, and British
Gynaecological Cancer Society (1996) have advocated the devel-
opment of specialist gynaecological oncology centres and units.
These developments are intended to improve compliance with
management guidelines, and will be the subject of a further audit
following implementation.
The results of this study were presented both as an oral presen-
tation and poster at the Bristol Meeting of the British
Gynaecological Cancer Society, 7–8 November 1997, and as an
oral presentation at the Manchester Ovarian Group Meeting,
15 January 1998.
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